Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-19-015257)

Filing Details

Accession Number:
0001209191-19-015257
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-01 20:01:00
Reporting Period:
2019-02-28
Accepted Time:
2019-03-01 20:01:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352238 Louis David Johnson C/O Dynavax Technologies
2929 Seventh Street, Suite 100
Berkeley CA 94710		 Vice President No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-02-28 5,125 $9.05 52,786 No 4 F Direct
Common Stock Disposition 2019-02-28 4,687 $9.03 48,099 No 4 S Direct
Common Stock Disposition 2019-02-28 9,703 $9.03 38,396 No 4 S Direct
Common Stock Disposition 2019-02-28 6,375 $9.03 32,021 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reporting person is reporting the sale of 5,125 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 28, 2019.